Assessment of the Effect of Periodontal Disease Prediction System on Oral Hygiene Motivation

NCT06577246 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2024-08-29

No results posted yet for this study

Summary

The aim of this trial is to evaluate the effect of patient specific periodontal disease prediction (PDP) system, a part of motivational interview, (MI) on probing depth (PD), Rustogi modified Navy Plaque Index (RMNPI), and papillary bleeding index (PBI) scores in patients with periodontitis following non-surgical periodontal therapy.

Conditions

  • Motivational Interviewing
  • Computer-Aided Design
  • Periodontal Diseases

Interventions

PROCEDURE

scaling root planing

periodontal treatment in all groups was performed using ultrasonic and hand instruments (#15/30, #6/7) by the same physician (UGE) who was blind to the study groups.

BEHAVIORAL

Three-Dimensional Animation (video1-2)

The video used in the study was created by DentalMaster (MD Stimulation Ltd) by combining their own footage (http://www.mdsimulation.com/). This video is divided into three parts, summarized below: * i. Overview of the causes and symptoms of periodontal disease (section 1) * ii. Treatment of periodontal disease and daily oral care practices for individuals (section 2)

BEHAVIORAL

Three-Dimensional Animation (video 3)

iii.Consequences of periodontal disease (such as gingival recession and tooth loss) that individuals may face if periodontal diseases are not treated and if they do not perform regular oral care (section 3). In this group, patients watch the video together with the physician (SG), who is familiar with the randomized patient groups.

BEHAVIORAL

Periodontal Disease Prediction (PDP)

The patients in the test group viewed sections 1 and 2 videos in the same manner as the 3DA group. However, unlike the 3DA group, they did not view section 3. Instead, they were shown estimates of their current condition and potential future periodontal tissue loss (gingival recession) for 1-5 years, 5-10 years, and 10-20 years. These projections were presented to the patients in three dimensions with PDP visualisation.

Sponsors & Collaborators

  • Abant Izzet Baysal University

    collaborator OTHER
  • The Scientific and Technological Research Council of Turkey

    collaborator OTHER
  • Bezmialem Vakif University

    lead OTHER

Principal Investigators

  • Sadiye Gunpinar, Asc. Prof. · Bezmialem Vakif University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-06-01
Primary Completion
2023-07-24
Completion
2023-07-24

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06577246 on ClinicalTrials.gov